Health

Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects

HANGZHOU, China, April 4, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has recently completed phase I trials in healthy subjects inChina for its self-developed innovative intestina...

2023-04-04 20:00 2808

Latest Updates of 6 Viva's Portfolio Companies

HONG KONG, April 4, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the suc...

2023-04-04 19:39 2415

Cambrex Opens New Stability Storage Facility in Belgium

EAST RUTHERFORD, N.J., April 4, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that their stability storage business, Q1 Sc...

2023-04-04 15:00 2054

iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model.

* Secured the effectiveness confirming data of PHAGERIA® technology for colorectal cancer organoids * The first target cancer type of PHAGERIA® technology is colorectal cancer (CRC) BOSTON and SEOUL, South Korea, April 3, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON",www.intodeworld.com...

2023-04-04 10:33 2142

Bridgewest Group completes acquisition of sterile injectable manufacturing plant in Western Australia from Pfizer

MIAMI and PERTH, Australia, April 4, 2023 /PRNewswire/ -- Global private investment firm,Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, announces that it has completed the acquisition of thePerth sterile injectable manufacturing facilit...

2023-04-04 10:00 2796

BioDuro-Sundia Wins Life Sciences Review Top 10 BPO Award

IRVINE, Calif., April 4, 2023 /PRNewswire/ -- Life Sciences Review magazine recognizes BioDuro-Sundia as top 10 Business Process Outsourcing (BPO). BioDuro-Sundia earned this award for its high-quality service and cutting-edge technology, as well as its integrated contract research, development a...

2023-04-04 08:30 2662

Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects

HANGZHOU, China, April 4, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has recently completed phase I trials in healthy subjects inChina for its self-developed innovative intestina...

2023-04-04 08:00 2720

AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc.

NEW YORK, April 3, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform foc...

2023-04-03 21:00 2882

GC Cell and New Management Embarking on a New Chapter

* Securing future growth engine by scouting global talents; AGM resolved new CEOJames Park and CTO Ho-won Kim as internal directors * Setting business goals focusing on change and growth * Proposing a new corporate vision of "Global Creator of Cell & Gene Therapy" YONGIN,South Korea, April 3...

2023-04-03 16:47 2156

Timekettle AI Translator Earbuds Empower International Medical Workers

SHENZHEN, China, April 3, 2023 /PRNewswire/ -- Technology company, Timekettle, recently sponsored the 13th Global Implantology Week organized by the ZimVie Association atNew York University. The four-day event brought together medical experts from over 30 countries to share their knowledge and ex...

2023-04-03 16:17 1684

Harbour BioMed Reports Full Year 2022 Financial Results

CAMBRIDGE, Mass., SUZHOU, China and ROTTERDAM, Netherlands, April 3, 2023 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncolo...

2023-04-03 15:10 3547

Perisai Paves the Way in Asia - Introducing Voice and Behavioral Risk Assessment for Insurance and Health Sectors.

SINGAPORE, April 3, 2023 /PRNewswire/ -- Voicesense and Bizbaz announce a new joint product called Perisai—Malay forShield. Specifically designed for insurance, reinsurance, health and wellness companies, Perisai builds on the partners' existing cooperation in finance, e-commerce, mental health a...

2023-04-03 15:00 8483

The World's Second Approved Biosimilars of Denosumab (MAILISHU)

SHANGHAI, April 3, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that the Denosumab solution for injection (trade name: MAILISHU, project code: 9MW0311), which is developed by its wholly-owned subsidiary T-m...

2023-04-03 13:44 1861

Tiens Group Attends Boao Forum for Asia Annual Conference 2023

Tiens focuses on global markets by engaging with likeminded peers from the four corners of the globe BOAO, China, April 3, 2023 /PRNewswire/ -- The highly anticipated Boao Forum forAsia (BFA) Annual Conference 2023 themed "An Uncertain World: Solidarity and Cooperation for Development amid Chall...

2023-04-03 10:39 3053

CBC Group Appoints Healthcare Veteran Abbas Hussain as Operating Partner

SINGAPORE, March 31, 2023 /PRNewswire/ -- Singapore-headquartered asset management firm, CBC Group ("CBC"), is pleased to announce the appointment of healthcare industry veteran, Abbas Hussain, as Operating Partner. In this role, Abbas will closely partner with CBC's business teams to identify, ...

2023-04-01 10:00 3646

AAHRPP Accredits Two More Research Organizations, Including Another in China

WASHINGTON, April 1, 2023 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs has accredited two more research organizations: a nonprofit health system in the American Midwest and another organization inChina. The newly accredited organizations are: * A...

2023-04-01 01:10 4812

Henlius 2022 Annual Results: Significant Achievements in Commercialisation, Surged to RMB3.2 Billion in Revenues

SHANGHAI, April 1, 2023 /PRNewswire/ -- Henlius (2696.HK) announced its 2022 annual results. In 2022, Henlius' revenue reached aboutRMB3.2147 billion, representing an increase of 91.1% YoY, primarily due to sales revenue and licensing revenue generated by the successive commercialisation of vario...

2023-04-01 00:06 9028

Tianlong Announces Global Release of GeneFlex Nucleic Acid Extractor and Gentier mini+ Real-time PCR System

Featuring flexibility and portability, the two products are ideal for small laboratories or on-site testing needs. XI'AN, China, March 31, 2023 /PRNewswire/ -- Tianlong , an innovative high-tech company specializing in molecular diagnostic products, has announced the glob...

2023-03-31 20:04 3385

Qiming Venture Partners Welcomes Apollomics' Successful IPO on Nasdaq

SHANGHAI, March 31, 2023 /PRNewswire/ -- On March 30, 2023, Apollomics Inc. ("Apollomics"), an innovative biopharmaceutical company and portfolio company of Qiming Venture Partners, listed on Nasdaq through a SPAC merger with Maxpro Capital Acquisition Corp. The combined company is now traded und...

2023-03-31 20:01 4454

Hugel Appointed Suk-yong Cha as Executive Chairman and Chairman of the Board Accelerating Transformation into a Global Top-tier Company

- Appointed as Executive Chairman and Chairman of the Board at the General Meeting of Shareholders and Board of Directors meeting on the 30th - Chairman Cha will lead the growth of Hugel based on his aesthetics know-how and experience in pioneering global markets SEOUL, South Korea, March 31, 20...

2023-03-31 20:00 1945
1 ... 246247248249250251252 ... 848